2TAMAI H, SUDO T, KIMURA A, et al. Association between the DRBI * 08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J]. Ann Intern Med, 1996,124:490--494.
3HARPER L,CHIN L,DAYKIN J, et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease[J]. Clin Endoerinol, 2004,60:671 -- 675.
5TAJIRI J, NOC-UCHI S. Antithyroid drug-induced agranulocytosis., special reference to normal white blood cell count agranulocytosis[J]. Throid, 2004 ,14: 459--462.
6TAKATA K, KUBOTA S,FUKATA S, et al. Methimazole-induced agranuloeytosis in patients with Graves'disease is more frequent with an initial dose of 30rag daily than with 15 mg daily[J].Thyroid,2009, 19:559--563.
二级参考文献4
1Chen Q Y，J Clin Endoc Metab，1999年，84卷，3182页
2Weitzman SA,Stoesel TP,Harmon DC,et al.Antineutrophil autoantibodies in Graves'disease,Implications of thyropin binding to neutrophils [J]. J Clin Invest,1985,75:119-123.
3Gutty MM,Goeken NE,Bruno CP.Granulocytotoxic antibodies in a patient with propyhhiouracil-induced agranulocytosis[J].Arch Intern Meal, 1984,144:1687-1688.
4Tarmai H,Sodo T,Kimura A,et al.Association between the DRBI * 08032 histocompatibility antigen and methimazole-induced ageanulocytosis in Japanese patients with Graves disease[J].Atom Intern Med, 1996,124:490-494.
